ImageneBio (IMA) Retained Earnings (2020 - 2025)
ImageneBio's (IMA) quarterly Retained Earnings came in at -$230.1 million in Q4 2025, down 12744.95% year-on-year from N/an in Q4 2024, and down 244837.23% quarter-over-quarter from $94000.0 in Q3 2025.
ImageneBio (IMA) Retained Earnings (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Retained Earnings across 6 years of filings, most recently posting -$230.1 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$230.1 million, down 12744.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$230.1 million (down 12744.95% YoY), and the FY2025 annual result was -$230.1 million, down 12744.95% from the prior year.
- Retained Earnings came in at -$230.1 million for Q4 2025 at ImageneBio, down from $94000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $94000.0 in Q3 2025 to a low of -$343.0 million in Q2 2025.
- The 5-year median for Retained Earnings is -$139.6 million (2021), against an average of -$134.0 million.
- Across the five-year window, Retained Earnings tumbled 111105.17% in 2024 and soared 100.03% in 2025, its largest moves.
- ImageneBio's Retained Earnings stood at -$145.5 million in 2021, then soared by 99.48% to -$763000.0 in 2022, then tumbled by 36909.83% to -$282.4 million in 2023, then surged by 99.37% to -$1.8 million in 2024, then plunged by 12744.95% to -$230.1 million in 2025.
- The last three Retained Earnings figures came in at -$230.1 million (Q4 2025), $94000.0 (Q3 2025), and -$343.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | -230.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -230.05 Mn |
| Sep 30, 2025 | 94,000.00 |
| Jun 30, 2025 | -343.01 Mn |
| Mar 31, 2025 | -340.24 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Sep 30, 2024 | -322.50 Mn |
| Jun 30, 2024 | -350,000.00 |
| Mar 31, 2024 | -313,000.00 |
| Dec 31, 2023 | -282.39 Mn |
| Sep 30, 2023 | -290,000.00 |
| Jun 30, 2023 | -245.55 Mn |
| Mar 31, 2023 | -491,000.00 |
| Dec 31, 2022 | -763,000.00 |
| Sep 30, 2022 | -200.12 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | -162.29 Mn |
| Dec 31, 2021 | -145.45 Mn |
| Sep 30, 2021 | -148.25 Mn |
| Jun 30, 2021 | -133.74 Mn |
| Mar 31, 2021 | -121.06 Mn |